AP1878A - Broadspectrum 2-amino-benzothiazole sulfonamide HIV protease inhibitors. - Google Patents

Broadspectrum 2-amino-benzothiazole sulfonamide HIV protease inhibitors.

Info

Publication number
AP1878A
AP1878A AP2005003242A AP2005003242A AP1878A AP 1878 A AP1878 A AP 1878A AP 2005003242 A AP2005003242 A AP 2005003242A AP 2005003242 A AP2005003242 A AP 2005003242A AP 1878 A AP1878 A AP 1878A
Authority
AP
ARIPO
Prior art keywords
broadspectrum
amino
protease inhibitors
hiv protease
benzothiazole sulfonamide
Prior art date
Application number
AP2005003242A
Other languages
English (en)
Other versions
AP2005003242A0 (en
Inventor
Dominique Louis Nestor Ghislain Surleraux
Piet Tom Bert Paul Wigerinck
Daniel P Getman
Original Assignee
Tibotec Pharm Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tibotec Pharm Ltd filed Critical Tibotec Pharm Ltd
Publication of AP2005003242A0 publication Critical patent/AP2005003242A0/xx
Application granted granted Critical
Publication of AP1878A publication Critical patent/AP1878A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/428—Thiazoles condensed with carbocyclic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D277/62—Benzothiazoles
    • C07D277/68—Benzothiazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D277/82—Nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • AIDS & HIV (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
AP2005003242A 2002-08-02 2003-08-04 Broadspectrum 2-amino-benzothiazole sulfonamide HIV protease inhibitors. AP1878A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP02078231 2002-08-02
US42786202P 2002-11-20 2002-11-20
PCT/EP2003/050359 WO2004014371A1 (en) 2002-08-02 2003-08-04 Broadspectrum 2-amino-benzothiazole sulfonamide hiv protease inhibitors

Publications (2)

Publication Number Publication Date
AP2005003242A0 AP2005003242A0 (en) 2005-03-31
AP1878A true AP1878A (en) 2008-08-13

Family

ID=31716850

Family Applications (1)

Application Number Title Priority Date Filing Date
AP2005003242A AP1878A (en) 2002-08-02 2003-08-04 Broadspectrum 2-amino-benzothiazole sulfonamide HIV protease inhibitors.

Country Status (16)

Country Link
US (2) US20050267156A1 (xx)
EP (1) EP1545518A1 (xx)
KR (1) KR20050025647A (xx)
CN (1) CN1671380B (xx)
AP (1) AP1878A (xx)
AU (1) AU2003262561B2 (xx)
BR (1) BR0305717A (xx)
CA (1) CA2492832C (xx)
EA (1) EA008594B1 (xx)
HR (1) HRP20050605A2 (xx)
IL (1) IL166257A (xx)
MX (1) MXPA05001275A (xx)
NO (1) NO20051089L (xx)
NZ (1) NZ538488A (xx)
PL (1) PL374948A1 (xx)
WO (1) WO2004014371A1 (xx)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2566340C (en) * 2004-05-07 2014-05-06 Sequoia Pharmaceuticals, Inc. Resistance-repellent retroviral protease inhibitors
JO2841B1 (en) * 2006-06-23 2014-09-15 تيبوتيك فارماسيوتيكالز ليمتد 2-(substituted-amino) -benzothiazole sulfonamide as protease inhibitors HIV (HIV)
US8267163B2 (en) * 2008-03-17 2012-09-18 Visteon Global Technologies, Inc. Radiator tube dimple pattern
WO2011061590A1 (en) 2009-11-17 2011-05-26 Hetero Research Foundation Novel carboxamide derivatives as hiv inhibitors
MX2012015097A (es) 2010-07-02 2013-05-28 Gilead Sciences Inc Derivados de acido naft-2-ilacetico para tratar sida.
TWI458711B (zh) 2010-07-02 2014-11-01 Gilead Sciences Inc 治療性化合物
US9024038B2 (en) 2010-12-27 2015-05-05 Purdue Research Foundation Compunds and methods for treating HIV
MX2013012266A (es) 2011-04-21 2013-11-22 Gilead Sciences Inc Compuestos de benzotiazol y su uso farmaceutico.
WO2013103738A1 (en) 2012-01-04 2013-07-11 Gilead Sciences, Inc. Napthalene acetic acid derivatives against hiv infection
US9376392B2 (en) 2012-01-04 2016-06-28 Gilead Sciences, Inc. 2-(tert-butoxy)-2-(7-methylquinolin-6-yl) acetic acid derivatives for treating AIDS
SG11201401189WA (en) 2012-04-20 2014-09-26 Gilead Sciences Inc Benzothiazol- 6 -yl acetic acid derivatives and their use for treating an hiv infection

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995006030A1 (en) * 1993-08-24 1995-03-02 G.D. Searle & Co. Hydroxyethylamino sulphonamides useful as retroviral protease inhibitors
WO1999067254A2 (en) * 1998-06-23 1999-12-29 The United States Of America Represented By The Secretary, Department Of Health And Human Services Multi-drug resistant retroviral protease inhibitors and use thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5968942A (en) * 1992-08-25 1999-10-19 G. D. Searle & Co. α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
ATE343567T1 (de) * 2001-02-14 2006-11-15 Tibotec Pharm Ltd Breitspektrum 2-(substituierte-amino)- benzothiazol-sulfonamide hiv protease inhibitoren

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995006030A1 (en) * 1993-08-24 1995-03-02 G.D. Searle & Co. Hydroxyethylamino sulphonamides useful as retroviral protease inhibitors
WO1999067254A2 (en) * 1998-06-23 1999-12-29 The United States Of America Represented By The Secretary, Department Of Health And Human Services Multi-drug resistant retroviral protease inhibitors and use thereof

Also Published As

Publication number Publication date
HRP20050605A2 (en) 2006-02-28
US20090203742A1 (en) 2009-08-13
EA200500298A1 (ru) 2005-08-25
MXPA05001275A (es) 2005-04-28
EA008594B1 (ru) 2007-06-29
BR0305717A (pt) 2004-09-28
IL166257A0 (en) 2006-01-15
NZ538488A (en) 2007-10-26
WO2004014371A1 (en) 2004-02-19
AU2003262561B2 (en) 2008-10-16
AU2003262561A1 (en) 2004-02-25
EP1545518A1 (en) 2005-06-29
AP2005003242A0 (en) 2005-03-31
CA2492832C (en) 2012-05-22
CN1671380B (zh) 2010-05-26
PL374948A1 (en) 2005-11-14
IL166257A (en) 2013-04-30
US20050267156A1 (en) 2005-12-01
CN1671380A (zh) 2005-09-21
KR20050025647A (ko) 2005-03-14
NO20051089L (no) 2005-05-02
CA2492832A1 (en) 2004-02-19

Similar Documents

Publication Publication Date Title
IL166257A0 (en) Broadspectrum 2-amino-benzothiazole sulfonamide HIV protease inhibitors
IL179056A0 (en) An hiv protease inhibitor
EP1483254A4 (en) INHIBITORS OF ANTI-RESISTANCE RETROVIRAL PROTEASE
EP1499336A4 (en) PROTEASE INHIBITORS
HK1076099A1 (en) Broadspectrum substituted benzisoxazole sulfonamide hiv protease inhibitors
AP2003002856A0 (en) Broadspectrum 2-(substitutted-amino)-benzothiazolesulphonamide HIV protease inhibitors.
AP2003002904A0 (en) Broadspectrum 2-amino-benzoxazole sulfonamide HIV protease inhibitors.
DE602004018701D1 (de) Alkalische Protease
AU2003234630A1 (en) Cysteine protease inhibitors
HK1072053A1 (en) Broadspectrum substituted benzimidazole sulfonamide hiv protease inhibitors
DK1347044T3 (da) Alkalisk protease
PL375307A1 (en) Broadspectrum substituted oxindole sulfonamide hiv protease inhibitors
AU2003269984A8 (en) Protease inhibitors
ZA200500926B (en) Broadspectrum 2-amino-benzothiazole sulfonamide HIV protease inhibitors
EP1511745A4 (en) PROTEASE INHIBITORS
AU2003287325A8 (en) N-cycloalkylglycines as hiv protease inhibitors
BR0317312B8 (pt) adaptador.
AU2003233642A8 (en) Protease inhibitors
EP1578429A4 (en) PROTEASE INHIBITORS
AU2003265240A8 (en) Protease inhibitors
EP1532115A4 (en) INHIBITORS OF PROTEASE
AU2002255485A8 (en) Hiv/fiv protease inhibitors
AU2003230545A1 (en) Resistance-repellent retroviral protease inhibitors